Celldex Therapeutics, Inc. Income Statement

Income Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 15.18M46.79M9.27M11.20M4.11M3.59M5.48M6.79M12.74M9.54M3.57M7.42M4.65M2.36M6.88M7.02M
Gross Profit 6.78M34.72M0.15M0.43M1.78M3.59M5.48M6.79M12.74M9.54M3.57M7.42M4.65M2.36M6.88M7.02M
Operating items
Amortization - Intangibles 0.95M3.14M1.91M1.09M1.01M1.01M1.01M1.00M0.90M0.22M
Research & Development 26.17M27.65M32.44M47.40M67.40M104.38M100.17M102.73M96.17M66.45M42.67M42.53M53.31M82.26M118.01M163.55M
Selling, General & Administrative 17.12M10.38M9.19M10.02M14.80M20.62M33.84M35.98M25.00M19.27M15.43M14.46M20.49M27.20M30.91M38.55M
Other Operating Expenses 0.60M0.05M0.05M11.87M3.35M1.01M1.01M1.00M0.80M29.62M1.29M4.22M1.41M-15.00M-12.50M
Operating Expenses 52.03M53.25M52.66M69.28M85.55M126.02M135.02M139.70M134.27M165.97M58.60M70.77M75.89M117.59M161.43M202.10M
Operating Income -36.85M-6.46M-43.40M-58.08M-81.44M-122.43M-129.54M-132.92M-121.53M-156.44M-55.03M-63.35M-71.24M-115.23M-154.54M-195.08M
EBIT -36.85M-6.46M-43.40M-58.08M-81.44M-122.43M-129.54M-132.92M-121.53M-156.44M-55.03M-63.35M-71.24M-115.23M-154.54M-195.08M
Non-operating items
Interest & Investment Income 5.26M0.40M0.53M0.82M4.35M2.34M4.39M4.21M4.49M4.15M2.41M0.51M2.91M13.11M37.22M
Non Operating Income 0.25M5.26M0.40M0.15M0.33M
Net income details
EBT -37.05M-2.53M-44.80M-59.12M-81.55M-118.08M-127.20M-128.53M-117.31M-151.95M-50.88M-60.95M-70.74M-112.33M-141.43M-157.86M
Tax Provisions -0.53M-24.28M-0.77M-1.17M-0.23M
Profit After Tax -36.52M-2.53M-44.80M-59.12M-81.55M-118.08M-127.20M-128.53M-93.03M-151.18M-50.88M-59.78M-70.51M-112.33M-141.43M-157.86M
Income from Continuing Operations -36.52M-2.53M-44.80M-59.12M-81.55M-118.08M-127.20M-128.53M-93.03M-151.18M-50.88M-59.78M-70.51M-112.33M-141.43M-157.86M
Consolidated Net Income -36.52M-2.53M-44.80M-59.12M-81.55M-118.08M-127.20M-128.53M-93.03M-151.18M-50.88M-59.78M-70.51M-112.33M-141.43M-157.86M
Income towards Parent Company -36.52M-2.53M-44.80M-59.12M-81.55M-118.08M-127.20M-128.53M-93.03M-151.18M-50.88M-59.78M-70.51M-112.33M-141.43M-157.86M
Net Income towards Common Stockholders -36.52M-2.53M-44.80M-59.12M-81.55M-118.08M-127.20M-128.53M-93.03M-151.18M-50.88M-59.78M-70.51M-112.33M-141.43M-157.90M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 2.11M2.14M2.94M5.37M5.95M5.97M6.58M6.75M9.07M11.50M16.13M39.57M46.74M47.10M47.26M66.34M
Shares Outstanding (Diluted Average) 19.82M31.87M39.50M0.01M0.03M0.04M0.05M0.05M0.06M
EBITDA -36.85M-6.46M-43.40M-58.08M-81.44M-118.16M-127.48M-128.30M-93.01M-151.16M-50.84M-59.81M-71.21M-112.96M-139.38M-157.86M
Tax Rate 0.00M0.00M0.00M0.00M0.00M